Evaluation of the nucleolar organizer region associated proteins in minor salivary gland tumors
Willie F. P. van Heerden, Erich J. Raubenheimer
Abstract
Willie F. P. van Heerden, Erich J. Raubenheimer
Abstract
Forty-three intraoral salivary gland tumors were studied to determine the value of the AgNOR technique in the assessment of these neoplasms. Well defined black dots were visible in the nucleii of all the specimens studied. The mean AgNOR count per nucleus for each tumor was calculated as follows: pleomorphic adenoma (n = 15) 1.52; Polymorphous low-grade adenocarcinoma (n = 12) 1.90; adenoid cystic carcinoma (n = 6) 2.92; mucoepidermoid carcinoma (n = 4) 1.93; carcinoma ex mixed tumor (n = 4) 2.05; undifferentiated carcinoma (n = 1) 3.13 and epithelial-myoepithelial carcinoma (n = 1) 2.23. The difference between the means of benign and malignant tumors (P less than 0.01) and polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma (P less than 0.01) were highly significant. The overlapping of the AgNOR count between various tumors prohibited the use of this technique as an absolute criterion in establishing a final diagnosis. It could however be used as a diagnostic aid in differentiating between salivary gland neoplasms.
OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Forty-three intraoral salivary gland tumors were studied to determine the value of the AgNOR technique in the assessment of these neoplasms. Well defined black dots were visible in the nucleii of all the specimens studied. The mean AgNOR count per nucleus for each tumor was calculated as follows: pleomorphic adenoma (n = 15) 1.52; Polymorphous low-grade adenocarcinoma (n = 12) 1.90; adenoid cystic carcinoma (n = 6) 2.92; mucoepidermoid carcinoma (n = 4) 1.93; carcinoma ex mixed tumor (n = 4) 2.05; undifferentiated carcinoma (n = 1) 3.13 and epithelial-myoepithelial carcinoma (n = 1) 2.23. The difference between the means of benign and malignant tumors (P less than 0.01) and polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma (P less than 0.01) were highly significant. The overlapping of the AgNOR count between various tumors prohibited the use of this technique as an absolute criterion in establishing a final diagnosis. It could however be used as a diagnostic aid in differentiating between salivary gland neoplasms.
Key concepts: Mucoepidermoid carcinoma, Adenoid cystic carcinoma, Pleomorphic adenoma, Salivary gland, Pathology, Adenocarcinoma, Carcinoma, Carcinoma ex pleomorphic adenoma